Beyond the Static List: Why Healthcare Account Targeting Is Becoming a Blending Problem | NPLUS Global

For years, "target account list" in healthcare sales meant a spreadsheet built from firmographic filters — bed count, specialty mix, EHR vendor, IDN affiliation, geography. It was stable, defensible, and almost entirely blind to timing. A 400-bed academic medical center that fit the ICP perfectly in Q1 might be in year three of a five-year contract with a competitor, with zero appetite to talk. The list didn't know that. It just knew the account looked right on paper.

That gap is what's pushing intent data into mainstream use across healthcare go-to-market teams, even in a sector that has historically been slower than tech or SaaS to adopt it. But the way healthcare teams are actually using intent signals is starting to diverge from how the martech playbook originally described it — and that divergence is worth paying attention to, because it says something about where account-based targeting is headed industry-wide.

Firmographics Were Never Meant to Predict Timing

Firmographic segmentation answers a "fit" question: does this organization have the structural characteristics of an account that could plausibly buy? It's a filter, not a forecast. That's fine when the filter is doing what it's designed for — narrowing a universe of tens of thousands of provider organizations down to a workable few thousand. The trouble starts when teams treat the filtered list as a prioritization tool instead of just a qualification tool.

A growing share of healthcare sales and marketing leaders now openly admit that their static ICP lists were essentially ranked by nothing — or by whatever the rep's gut said, or by whichever accounts happened to answer the phone. The list told you who; it never told you now. And in healthcare specifically, "now" is unusually hard to guess from the outside, because purchasing cycles are shaped by things firmographic data can't see: a new CMIO six months into the job, a compliance deadline nobody publicizes, a contract renewal buried in procurement that won't surface publicly until it's already been decided.

This is the structural reason intent data has become attractive. It's not that firmographics stopped mattering — fit still matters enormously — it's that fit alone stopped being a useful ranking mechanism once teams had more qualified accounts than they had capacity to work.

Intent Signals Behave Differently in Healthcare Than in Other B2B Categories

Here's where it gets more interesting, and where a lot of generic intent-data advice falls apart when applied to healthcare. In most B2B categories, intent monitoring assumes a reasonably concentrated buying committee researching a reasonably well-defined problem. Healthcare breaks both assumptions.

First, research activity in healthcare organizations is diffuse and often disconnected from purchasing authority. A clinical staff member researching a device category might be doing so for continuing education, a journal club, a credentialing requirement, or genuine evaluation — and from the outside, those look identical. Compliance and risk staff research vendors for reasons that have nothing to do with near-term buying. It's becoming common for teams that adopted intent data early to report that raw account-level intent spikes, without more context, produced a lot of false positives — enough that some reps started ignoring the alerts altogether, which defeats the purpose.

Second, and more structurally important: the entity doing the researching and the entity that actually signs are frequently not the same node in the org chart. A facility-level administrator might be the one consuming content, while the purchasing decision — and the budget — sits two or three layers up at the system or IDN level. Intent data that's scored at the facility level can point sales reps at exactly the right building and exactly the wrong buyer.

The Real Bottleneck Isn't the Data — It's the Hierarchy

This is the part of the conversation that doesn't get enough attention in vendor pitches, but it's the part experienced data ops and RevOps people keep coming back to: blending firmographic and intent signals only works if both are resolved to the same account hierarchy. If your firmographic data lives at the health system level and your intent signals resolve to an individual NPI or a single facility, "combining" them is really just juxtaposing two lists that don't talk to each other.

Healthcare's org structures make this unusually hard compared to other verticals. A single physical location might belong to a group practice that was acquired by a larger group that's affiliated with, but not owned by, a regional IDN — and each of those entities might have its own domain, its own web traffic, its own separate intent footprint. Teams working through providers like NPLUS Global, which builds healthcare-specific firmographic and organizational data as its core business, tend to spend more of their integration effort on this matching problem than on the intent layer itself, because getting the hierarchy right is what makes the rest of the model mean anything.

What this means practically: the teams getting real value out of combined targeting aren't the ones with the most intent sources. They're the ones who've done the unglamorous work of mapping facility-to-system-to-parent relationships accurately enough that a signal picked up at one node can be rolled up — or pushed down — to the account level where the actual buying decision happens.

Where This Is Heading

The direction is fairly clear even if the tooling is still maturing: static, evenly-weighted ICP lists are giving way to dynamic, tiered account scores that treat firmographic fit as the qualifying gate and intent as a moving priority signal layered on top of a correctly resolved hierarchy. Account lists are starting to look less like fixed spreadsheets and more like live rankings that shift week to week as signal strength changes.

The teams that will pull ahead aren't necessarily the ones with the richest intent feeds. They're the ones treating entity resolution as a first-class problem rather than a data-cleanup afterthought — because in a fragmented, multi-layered market like healthcare provider services, that's the piece that turns two separate data streams into one usable answer about who to call, and when.